Laura Pearson

628 total citations
15 papers, 440 citations indexed

About

Laura Pearson is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Laura Pearson has authored 15 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Laura Pearson's work include Pharmacogenetics and Drug Metabolism (6 papers), Hormonal and reproductive studies (2 papers) and Pain Management and Opioid Use (1 paper). Laura Pearson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Hormonal and reproductive studies (2 papers) and Pain Management and Opioid Use (1 paper). Laura Pearson collaborates with scholars based in United States and Australia. Laura Pearson's co-authors include Joseph C. Fleishaker, Gary Peters, Raymond S. Lord, James P. Sams, K. S. Cathcart, J. Greg Slatter, David Baker, Larry J. Schaaf, Linda D. Compton and Kenneth L. Feenstra and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Laura Pearson

15 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Pearson United States 9 199 179 89 63 58 15 440
Toshimasa Ohnishi Japan 9 103 0.5× 271 1.5× 27 0.3× 158 2.5× 48 0.8× 14 443
Emi Hayashinaka Japan 13 123 0.6× 112 0.6× 28 0.3× 74 1.2× 16 0.3× 24 392
Giulia Ghibellini United States 12 71 0.4× 273 1.5× 130 1.5× 129 2.0× 41 0.7× 17 632
Rong Zhao China 9 79 0.4× 204 1.1× 68 0.8× 120 1.9× 28 0.5× 16 400
Armin Bruelisauer Switzerland 8 120 0.6× 136 0.8× 81 0.9× 80 1.3× 47 0.8× 10 474
Maribel Martínez United States 17 318 1.6× 68 0.4× 37 0.4× 22 0.3× 112 1.9× 24 840
Peng Hsiao United States 11 127 0.6× 465 2.6× 111 1.2× 316 5.0× 39 0.7× 12 698
R E Gregory United States 8 88 0.4× 98 0.5× 19 0.2× 52 0.8× 38 0.7× 9 438
Virginie M.M. Herben Netherlands 17 376 1.9× 380 2.1× 101 1.1× 121 1.9× 102 1.8× 26 985
Karin Tunblad Sweden 13 100 0.5× 189 1.1× 55 0.6× 148 2.3× 129 2.2× 21 502

Countries citing papers authored by Laura Pearson

Since Specialization
Citations

This map shows the geographic impact of Laura Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Pearson more than expected).

Fields of papers citing papers by Laura Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Pearson. The network helps show where Laura Pearson may publish in the future.

Co-authorship network of co-authors of Laura Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Pearson. A scholar is included among the top collaborators of Laura Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Pearson. Laura Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pearson, Laura. (2011). Exploring the Effectiveness of Mobile Phones to Support English Language Learning for Migrant Groups. 7(1). 90–105. 8 indexed citations
2.
Ellis, Michael D., et al.. (2011). Effects of body orientation on maximum voluntary arm torques. Muscle & Nerve. 44(5). 805–813. 5 indexed citations
3.
Pearson, Laura, et al.. (2008). A rapid flow cytometric technique for the detection of platelet‐monocyte complexes, activated platelets and platelet‐derived microparticles. International Journal of Laboratory Hematology. 31(4). 430–439. 16 indexed citations
4.
Kwekkeboom, Kristine L., et al.. (2003). A pilot study to predict success with guided imagery for cancer pain. Pain Management Nursing. 4(3). 112–123. 32 indexed citations
5.
Slatter, J. Greg, Larry J. Schaaf, James P. Sams, et al.. (2000). Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients. Drug Metabolism and Disposition. 28(4). 423–433. 241 indexed citations
6.
Fleishaker, Joseph C., et al.. (1999). Evaluation of the Potential Pharmacokinetic/Pharmacodynamic Interaction between Fluoxetine and Reboxetine in Healthy Volunteers. Clinical Drug Investigation. 18(2). 141–150. 10 indexed citations
7.
Fleishaker, Joseph C., Laura Pearson, Paul G. Pearson, et al.. (1999). Hormonal Effects on Tirilazad Clearance in Women: Assessment of the Role of CYP3A. The Journal of Clinical Pharmacology. 39(3). 260–267. 15 indexed citations
8.
Fleishaker, Joseph C., Laura Pearson, & Gary Peters. (1998). Induction of tirilazad clearance by phenytoin. Biopharmaceutics & Drug Disposition. 19(2). 91–96. 8 indexed citations
9.
Fleishaker, Joseph C., et al.. (1998). Biotransformation of Tirilazad in Human: 4. Effect of Finasteride on Tirilazad Clearance and Reduced Metabolite Formation. Journal of Pharmacology and Experimental Therapeutics. 287(2). 591–597. 5 indexed citations
10.
Pearson, Laura, Joseph C. Fleishaker, & Gary Peters. (1996). Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosis. European Journal of Clinical Pharmacology. 50(4). 299–304. 1 indexed citations
11.
Fleishaker, Joseph C., Paul G. Pearson, Larry C. Wienkers, Laura Pearson, & Gary Peters. (1996). Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 991–998. 22 indexed citations
12.
Fleishaker, Joseph C., Laura Pearson, & Gary Peters. (1996). Gender does not affect the degree of induction of tirilazad clearance by phenobarbital. European Journal of Clinical Pharmacology. 50(1-2). 139–145. 12 indexed citations
13.
Fleishaker, Joseph C., Laura Pearson, & Gary Peters. (1996). Effect of gender on the degree of induction of tirilazad clearance by phenytoin.. Clinical Pharmacology & Therapeutics. 59(2). 168–168. 1 indexed citations
14.
Fleishaker, Joseph C., Laura Pearson, & Gary Peters. (1995). Phenytoin Causes a Rapid Increase in 6β‐Hydroxycortisol Urinary Excretion in Humans—A Putative Measure of CYP3A Induction. Journal of Pharmaceutical Sciences. 84(3). 292–294. 54 indexed citations
15.
Pearson, Laura, et al.. (1965). CORRELATION OF PERCEPTUAL FACTORS WITH REHABILITATION OF HEMIPLEGIC PATIENTS.. PubMed. 46. 461–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026